Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Northrop Grumman Corporation’s Chief Financial Officer, John Greene, filed an initial ownership report stating that he beneficially owns no company securities. The Form 3 shows that as of 01/07/2026, he held 0 shares of common stock directly and reported no derivative securities such as options or warrants. A remark reiterates that no securities are beneficially owned, and a power of attorney is noted as an exhibit, indicating that the filing was submitted on his behalf by an attorney-in-fact.
Northrop Grumman (NOC) Chair, CEO and President Kathy J. Warden reported two open-market stock sales under a pre-arranged Rule 10b5-1 trading plan. On January 5, 2026, she sold 7,000 shares of Northrop Grumman common stock at $600 per share. On January 6, 2026, she sold an additional 3,000 shares at $615 per share. These transactions were executed pursuant to a Rule 10b5-1 plan adopted on September 2, 2025. After the reported sales, she directly beneficially owns 191,602.4 shares of Northrop Grumman common stock.
NOC shareholder Kathy J. Warden filed a notice to sell 3,000 shares of common stock with an aggregate market value of $1,845,000 through Fidelity Brokerage Services LLC, with an approximate sale date of January 6, 2026 on the NYSE.
The filing notes that there were 142,720,067 shares of common stock outstanding. The 3,000 shares to be sold were acquired on February 14, 2024 through restricted stock vesting from the issuer as compensation, with payment also dated February 14, 2024. Over the past three months, Warden previously sold 7,000 common shares on January 5, 2026 for gross proceeds of $4,200,000.
Northrop Grumman Corporation director reports routine equity compensation activity. On 12/31/2025, the director acquired 64 shares of Northrop Grumman common stock at $570.21 per share through deferral into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan, in a transaction exempt under Rule 16b-3. Following this transaction, the director beneficially owned 2,257 shares in the stock unit account. The filing notes that dividends credited on shares in this account are exempt from Section 16 and were not required to be reported.
Northrop Grumman reported an equity transaction by a company director. On 12/31/2025, the director acquired 81 shares of Northrop Grumman common stock at $570.21 per share. These shares were deferred into a stock unit account under the company’s 2024 Long-Term Incentive Stock Plan in a transaction that is exempt under Rule 16b-3.
Following this transaction, the director beneficially owned 10,963 shares of common stock in the stock unit account, which includes dividends credited under the plan. Dividends earned on these stock units were exempt from Section 16 reporting and therefore were not required to be reported as separate transactions.
Northrop Grumman insider filed a notice to sell company stock under Rule 144. The filing covers 7,000 shares of common stock, to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 4,200,000.00. The notice lists 142,720,067 shares outstanding of the same class of stock.
The shares planned for sale come from restricted stock vesting awards received from the issuer as compensation. The insider acquired 4,621 shares on 02/14/2024 and 2,379 shares on 02/16/2024, both labeled as compensation. The approximate date of sale is given as 01/05/2026. By signing, the seller represents they are not aware of undisclosed material adverse information about Northrop Grumman’s operations.
Northrop Grumman Corporation executive CVP & President, Mission Systems reported a small open-market stock sale. On December 9, 2025, the reporting person sold 84 shares of common stock at a price of $555.35 per share, coded as a sale transaction. This trade was made under a pre-arranged Rule 10b5-1 trading plan adopted on February 11, 2025.
After this transaction, the reporting person beneficially owned 403.91 shares of Northrop Grumman common stock directly. In addition, 114.1531 shares were held indirectly through the Northrop Grumman Savings Plan, a qualified defined contribution plan, as of December 9, 2025, where unit accounting can change reported units without a new purchase or sale.
A holder of NOC common stock has filed a notice of proposed sale on Form 144. The filing covers the planned sale of 84 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of 46649.40. The securities were acquired on 12/05/2025 via restricted stock vesting from the issuer as compensation, with payment also dated 12/05/2025. The filing notes that 142,720,067 shares of this class were outstanding, providing context for the size of the planned sale.
Northrop Grumman (NOC) executive reports stock transactions from restricted awards. On December 5, 2025, the company’s CVP & President, Mission Systems, exercised 328 Restricted Stock Rights, receiving the same number of common shares at an exercise price of $0. On the same date, 159 common shares were disposed of in a transaction coded “F,” reflecting shares withheld at a price of $548.97 per share, typically for tax purposes, leaving 646.91 common shares held directly afterward.
The reporting person also holds 114.1536 common shares indirectly through the Northrop Grumman Savings Plan as of December 5, 2025, where amounts are tracked using unit accounting. After the vesting and exercise activity, 6,829 Restricted Stock Rights remain beneficially owned as derivative securities, each representing a contingent right to receive one share of Northrop Grumman common stock or, at the issuer’s election, cash or a combination of cash and stock.
Northrop Grumman Corporation (NOC) reported insider activity by a director, who filed a Form 4 disclosing multiple open-market sales of common stock on 11/24/2025. The transactions were sales of very small share amounts, with prices ranging from about $560.39 to $566.15 per share. All sales are marked as dispositions and were made in the open market.
The director conducted these trades under a pre-established Rule 10b5-1 trading plan adopted on August 23, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following these transactions, the reporting person directly beneficially owns 4,281 shares of Northrop Grumman common stock.